Probiotics in the prevention of traveller's diarrhoea

Academic Medical Centre (AMC) (The Netherlands)0 个研究点目标入组 800 人开始时间: 2007年2月26日最近更新: 2021年8月30日

适应症

试验速览

暂无简介。

•1. Both male and female adults (+18)
•2. Travelling to high risk area's for Traveller's Diarrhoea (TD) (Middle East, Asia, South and Central America, North Africa)
•3. Duration of travelling: min. seven days, max. 28 days
•4. People who experienced TD before
•5. All new travellers to high risk areas

•1. Use of antibiotics until two weeks before leaving
•2. Use of laxatives, acid blockers and diarrhoea inhibitors
•3. Persons who already have complaints about their stomach and/or intestines
•4. Irritable Bowel Syndrome (IBS)/Irritable Bowel Disease (IBD) and stoma patients
•5. Pregnant or breastfeeding women
•6. Patients with a serious disturbed or fragile/weak immune system (according to the Dutch National Coordination Center for Travelers' Health Advice [LCR] criteria)
•7. Use of probiotics two weeks before start of journey
•8. Frequent traveller's to high risk area's who never had TD complaints

发起方

Academic Medical Centre (AMC) (The Netherlands)